GRF
GRIFOLS
Stock Bolsas y Mercados Españoles – Stock Market Prices, News & Analysis
Grifols S.A. is a biopharmaceutical company that focuses primarily on the production of plasma and plasma-derived products.
GRIFOLS
GRF
Grifols S.A. is a biopharmaceutical company that focuses primarily on the production of plasma and plasma-derived products.
Price history of GRIFOLS
Price history of GRIFOLS
Performance & Momentum
Strategic Analysis
GRIFOLS • 2026
Grifols S.A., based in Spain, operates in the biotechnology sector, specializing in the production of plasma and plasma-derived products that are essential for various medical treatments. Positioned as a leader in its segment, the company capitalizes on advanced technologies and innovative processes for plasma treatment.
Strengths
- Leader in the plasma treatment sector
- Continuous technological innovation in the production processes of plasma-derived products
- Extensive geographical presence with major operations in Europe and international diversification
Weaknesses
- Recent financial performance shows a significant loss of market value
- Sensitivity to strict biopharmaceutical regulations, impacting operations and costs
Momentum
Despite a relatively low current momentum and a negative performance trajectory over the past 5 years, the company remains a crucial player in its sector. Its ongoing innovation could position it for a gradual recovery if regulatory and market challenges are effectively managed.
Similar stocks to GRIFOLS
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
